MolNFT v1 · #182650 · protein
Crystal structure of the ucld lectin-binding domain
7MZP · F17-like fimbril adhesin subunit ucld: “Crystal structure of the ucld lectin-binding domain”. X-ray diffraction, 1 ligand (IOD), 1 pocket (best druggability 0.64). MolNFT v1 #182650 on GenesisL1: 3D structure, binding sites and…
- PDB
- 7MZP
- Type
- protein
- Length
- 375 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- F17-like fimbril adhesin subunit ucld
- UniProt
- A0A1X9VGE7
- Ligands
- IOD
- Pockets
- 1 · best druggability 0.64
Structure
x-ray diffraction · 2 distinct chains · 7% helix, 53% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | F17-like fimbril adhesin subunit ucld | protein | 187 | 7% helix, 53% strand | A0A1X9VGE7 |
| B | F17-like fimbril adhesin subunit ucld | protein | 188 | 7% helix, 53% strand | A0A1X9VGE7 |
Ligands and binding sites
- IOD · Iodide ion · ion · 6 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 588 | 0.64 | 0.75 | 71 | IOD |
Interfaces
1 interface between chains.
- A–B · 209 Ų buried · 1 hydrogen bond · protein-protein
Compared structures
- 7MZP · Crystal structure of the UclD lectin-binding domain · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A0A1X9VGE7
- Elsewhere: RCSB PDB 7MZP · PDBe 7MZP · UniProt A0A1X9VGE7
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.